Characterization of a serum inhibitor of MLC reactions. II. Molecular structure and dissociation of inhibition against responder and stimulator function.
D000017:ABO Blood-Group System; D000042:Absorption; D000818:Animals; D001426:Bacterial Proteins; D005591:Chemical Fractionation; D002850:Chromatography, Gel; D005260:Female; D006041:Goats / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular / Q000187:drug effects*; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G / Q000494:pharmacology; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008934:Mitogens; D010298:Parity; D011247:Pregnancy; D013210:Staphylococcus / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014373:Tuberculin
D000017:ABO Blood-Group System; D001426:Bacterial Proteins; D007106:Immune Sera; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D008934:Mitogens; D014373:Tuberculin; D014316:Tritium; D013936:Thymidine